Bexorg
New Haven, US · 4 known investors
Bexorg is a biotech platform for CNS drug discovery built on a whole-brain perfusion model that allows manipulation and recording of cellular activity in intact human brains. The company serves pharmaceutical researchers developing treatments for brain diseases.
Founders & leadership
ZV
Zvonimir Vrseljain
NS
Nenad Sestan
Investors · 4
In the news
- Bexorg Completes $23M Series A Bringing Total Funding to $42.5Morrick.com · 2025
- Bexorg Raises $42.5M to Transform CNS Drug Development with World’s First Integrated AI and Whole-Human Brain Platformglobenewswire.com · 2025
- Neuroscience start-up Bexorg nets $42.5 millioncen.acs.org · 2025
- Bexorg Raises $42.5 Million Led by Engine Ventures to Advance AI and Whole-Human Brain Platform for CNS Drug Discovery | citybizcitybiz.co · 2025
- Bexorg raises $23M to test drugs on ‘rebooted’ human brains from organ donorsendpoints.news · 2025